Genprex, Inc. Research and Development Expense
Genprex, Inc. (GNPX) reported Research and Development Expense of $2.68 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- Genprex, Inc. research and development expense for the quarter ending 2026-06-30 was $2.68M, a 7.36% increase year-over-year.
- Genprex, Inc. research and development expense for the quarter ending 2026-03-31 was $2.75M, a 8.11% increase year-over-year.
- Genprex, Inc. research and development expense for the quarter ending 2025-12-31 was $2.20M, a 22.62% decline year-over-year.
- Genprex, Inc. research and development expense for the quarter ending 2025-09-30 was $2.19M, a 20.43% decline year-over-year.
- Genprex, Inc. research and development expense for fiscal 2025 was $9.43M, a 10.50% decline from fiscal 2024.
- Genprex, Inc. research and development expense for fiscal 2024 was $10.54M, a 40.20% decline from fiscal 2023.
- Genprex, Inc. research and development expense for fiscal 2023 was $17.62M, a 53.05% increase from fiscal 2022.
- Genprex, Inc. research and development expense for fiscal 2022 was $11.51M, a 28.31% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.68M 10-Q · filed 2026-08-14 | $5.43M 10-Q · filed 2026-08-14 | $7.63M derived: sum of 3 quarters · filed 2026-08-14 | $9.82M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $2.75M 10-Q · filed 2026-05-13 | $4.94M derived: sum of 2 quarters · filed 2026-05-13 | $7.14M derived: sum of 3 quarters · filed 2026-05-13 | $9.63M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $4.39M derived: sum of 2 quarters · filed 2026-03-30 | $6.89M derived: sum of 3 quarters · filed 2026-08-14 | $9.43M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $2.19M 10-Q · filed 2025-11-14 | $4.69M derived: sum of 2 quarters · filed 2026-08-14 | $7.23M 10-Q · filed 2025-11-14 | $10.07M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $2.50M 10-Q · filed 2026-08-14 | $5.04M 10-Q · filed 2026-08-14 | $7.88M derived: sum of 3 quarters · filed 2026-08-14 | $10.63M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $2.54M 10-Q · filed 2026-05-13 | $5.38M derived: sum of 2 quarters · filed 2026-05-13 | $8.13M derived: sum of 3 quarters · filed 2026-05-13 | $9.80M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.59M derived: sum of 2 quarters · filed 2026-03-30 | $7.26M derived: sum of 3 quarters · filed 2026-03-30 | $10.54M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $2.76M 10-Q · filed 2025-11-14 | $4.42M derived: sum of 2 quarters · filed 2025-11-14 | $7.70M 10-Q · filed 2025-11-14 | $7.70M 10-Q · filed 2024-11-13 | $11.41M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $1.67M 10-Q · filed 2025-08-14 | $4.94M 10-Q · filed 2025-08-14 | $8.65M derived: sum of 3 quarters · filed 2025-08-14 | $13.27M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $3.27M 10-Q · filed 2025-05-12 | $6.99M derived: sum of 2 quarters · filed 2025-05-12 | $11.60M derived: sum of 3 quarters · filed 2025-05-12 | $15.58M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $8.33M derived: sum of 2 quarters · filed 2025-04-01 | $12.31M derived: sum of 3 quarters · filed 2025-04-01 | $17.62M 10-K · filed 2025-04-01 | ||||
| 2023-09-30 | $4.62M 10-Q · filed 2024-11-13 | $8.59M derived: sum of 2 quarters · filed 2024-11-13 | $13.90M 10-Q · filed 2024-11-13 | $17.29M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $3.98M 10-Q · filed 2024-08-09 | $9.29M 10-Q · filed 2024-08-09 | $12.67M derived: sum of 3 quarters · filed 2024-08-09 | $15.83M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $5.31M 10-Q · filed 2024-05-15 | $8.70M derived: sum of 2 quarters · filed 2024-05-15 | $11.85M derived: sum of 3 quarters · filed 2024-05-15 | $14.78M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $6.54M derived: sum of 2 quarters · filed 2024-04-01 | $9.47M derived: sum of 3 quarters · filed 2024-04-01 | $11.51M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $3.16M 10-Q · filed 2023-11-14 | $3.59M 10-Q · filed 2022-11-14 | $6.08M derived: sum of 2 quarters · filed 2023-11-14 | $8.12M 10-Q · filed 2023-11-14 | $8.19M 10-Q · filed 2022-11-14 | $11.97M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $2.93M 10-Q · filed 2023-08-21 | $2.74M 10-Q · filed 2022-08-12 | $4.97M 10-Q · filed 2023-08-21 | $4.60M 10-Q · filed 2022-08-12 | $8.81M derived: sum of 3 quarters · filed 2023-08-21 | $10.24M derived: sum of 4 quarters · filed 2023-08-21 | ||
| 2022-03-31 | $2.04M 10-Q · filed 2023-05-22 | $1.86M 10-Q · filed 2022-05-13 | $5.88M derived: sum of 2 quarters · filed 2023-05-22 | $7.32M derived: sum of 3 quarters · filed 2023-05-22 | $8.84M derived: sum of 4 quarters · filed 2023-05-22 | |||
| 2021-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.28M derived: sum of 2 quarters · filed 2023-03-31 | $6.80M derived: sum of 3 quarters · filed 2023-03-31 | $8.97M 10-K · filed 2023-03-31 | $8.61M 10-K · filed 2022-03-30 | |||
| 2021-09-30 | $1.43M 10-Q · filed 2022-11-14 | $2.96M derived: sum of 2 quarters · filed 2022-11-14 | $5.13M 10-Q · filed 2022-11-14 | $7.32M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-06-30 | $1.53M 10-Q · filed 2022-08-12 | $3.70M 10-Q · filed 2022-08-12 | $5.89M derived: sum of 3 quarters · filed 2023-03-31 | $7.24M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-03-31 | $2.04M 10-K · filed 2023-03-31 | $2.17M 10-Q · filed 2021-05-17 | $4.36M derived: sum of 2 quarters · filed 2023-03-31 | $5.71M derived: sum of 3 quarters · filed 2023-03-31 | $7.87M derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2020-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.67M derived: sum of 2 quarters · filed 2022-03-30 | $5.83M derived: sum of 3 quarters · filed 2022-03-30 | $7.30M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $1.35M 10-Q · filed 2021-11-15 | $3.51M derived: sum of 2 quarters · filed 2021-11-15 | $4.98M 10-Q · filed 2021-11-15 | $5.47M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $2.16M 10-Q · filed 2021-08-13 | $3.63M 10-Q · filed 2021-08-13 | $4.12M derived: sum of 3 quarters · filed 2021-08-13 | $4.59M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $1.48M 10-Q · filed 2021-05-17 | $1.97M derived: sum of 2 quarters · filed 2021-05-17 | $2.43M derived: sum of 3 quarters · filed 2021-05-17 | $2.94M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $489.58K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $956.92K derived: sum of 2 quarters · filed 2021-03-26 | $1.46M derived: sum of 3 quarters · filed 2021-03-26 | $1.97M 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $467.34K 10-Q · filed 2020-11-12 | $969.38K derived: sum of 2 quarters · filed 2020-11-12 | $1.48M 10-Q · filed 2020-11-12 | $1.79M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $502.04K 10-Q · filed 2020-08-11 | $1.01M 10-Q · filed 2020-08-11 | $1.33M derived: sum of 3 quarters · filed 2020-08-11 | $1.82M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $508.04K 10-Q · filed 2020-05-14 | $825.19K derived: sum of 2 quarters · filed 2020-05-14 | $1.31M derived: sum of 3 quarters · filed 2020-05-14 | $1.43M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $317.15K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $806.84K derived: sum of 2 quarters · filed 2020-03-30 | $919.81K derived: sum of 3 quarters · filed 2020-03-30 | $971.43K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $489.69K 10-Q · filed 2019-11-14 | $602.66K derived: sum of 2 quarters · filed 2019-11-14 | $654.28K 10-Q · filed 2019-11-14 | $715.35K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $112.97K 10-Q · filed 2019-08-13 | $164.59K 10-Q · filed 2019-08-13 | $225.66K derived: sum of 3 quarters · filed 2019-08-13 | $281.18K derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $51.62K 10-Q/A · filed 2019-05-20 | $112.69K derived: sum of 2 quarters · filed 2019-05-20 | $168.21K derived: sum of 3 quarters · filed 2019-05-20 | $273.19K derived: sum of 4 quarters · filed 2019-05-20 | ||||
| 2017-12-31 | $61.07K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $116.59K derived: sum of 2 quarters · filed 2019-04-01 | $221.57K derived: sum of 3 quarters · filed 2019-04-01 | $289.93K 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | $55.52K 10-Q · filed 2018-11-14 | $160.50K derived: sum of 2 quarters · filed 2018-11-14 | $228.86K 10-Q · filed 2018-11-14 | $358.20K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $104.98K 10-Q · filed 2018-08-14 | $173.34K 10-Q · filed 2018-08-14 | $302.68K derived: sum of 3 quarters · filed 2018-08-14 | $392.58K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $68.36K 10-Q · filed 2018-05-15 | $197.70K derived: sum of 2 quarters · filed 2018-05-15 | $287.60K derived: sum of 3 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | $129.34K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $219.23K derived: sum of 2 quarters · filed 2018-04-17 | $354.88K 10-K · filed 2018-04-17 | |||||
| 2016-09-30 | $89.90K 10-Q · filed 2017-12-05 | $225.55K 10-Q · filed 2017-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |